Actively Recruiting
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
Led by Alexion Pharmaceuticals, Inc. · Updated on 2026-02-18
500
Participants Needed
51
Research Sites
513 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Long-term, multicenter, multinational, observational, registry of patients with gMG that is designed to collect data on clinical outcomes and safety in patients prescribed Alexion C5 inhibitor therapies (C5IT) such as eculizumab (Soliris®) and ravulizumab (Ultomiris®).
CONDITIONS
Official Title
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of generalized myasthenia gravis treated with Alexion complement C5 inhibition therapies at enrollment, including those previously treated with Soliris or Ultomiris and withdrawn from treatment
- Ability to give signed informed consent, including agreeing to follow study requirements
- Availability of historical myasthenia gravis data, such as MG-ADL and MGFA class, for enrollment
You will not qualify if you...
- Current enrollment in any Alexion-sponsored interventional clinical study for generalized myasthenia gravis treatment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 51 locations
1
Clinical Trial Site
Birmingham, Alabama, United States, 35294
Actively Recruiting
2
Clinical Trial Site
Scottsdale, Arizona, United States, 85251
Actively Recruiting
3
Clinical Trial Site
Fresno, California, United States, 93710
Actively Recruiting
4
Clinical Trial Site
Orange, California, United States, 92868
Actively Recruiting
5
Clinical Trial Site
Rancho Mirage, California, United States, 92270
Actively Recruiting
6
Clinical Trial Site
Sylmar, California, United States, 91342
Actively Recruiting
7
Clinical Trial Site
Colorado Springs, Colorado, United States, 80907
Actively Recruiting
8
Clinical Trial Site
Fort Collins, Colorado, United States, 80528
Actively Recruiting
9
Clinical Trial Site
New Haven, Connecticut, United States, 06520
Actively Recruiting
10
Clinical Trial Site
Washington D.C., District of Columbia, United States, 10010
Actively Recruiting
11
Clinical Trial Site
Clearwater, Florida, United States, 33761
Actively Recruiting
12
Clincal Trial Site
Gainesville, Florida, United States, 32608
Actively Recruiting
13
Clinical Trial Site
Jacksonville, Florida, United States, 32209
Actively Recruiting
14
Clinical Trial Site
Tampa, Florida, United States, 33612
Actively Recruiting
15
Clinical Trial Site
Augusta, Georgia, United States, 30912
Actively Recruiting
16
Clinical Trial Site
Iowa City, Iowa, United States, 52242
Actively Recruiting
17
Clinical Trial Site
Lexington, Kentucky, United States, 40503
Actively Recruiting
18
Clinical Trial Site
Boston, Massachusetts, United States, 02215
Actively Recruiting
19
Clinical Trial Site
Lansing, Michigan, United States, 48824
Actively Recruiting
20
Clinical Trial Site
Columbia, Missouri, United States, 65212
Actively Recruiting
21
Clinical Trial Site
New Hyde Park, New York, United States, 11042
Actively Recruiting
22
Clinical Trial Site
Chapel Hill, North Carolina, United States, 27599
Actively Recruiting
23
Clinical Trial Site
Charlotte, North Carolina, United States, 28207
Actively Recruiting
24
Clinical Trial Site
Durham, North Carolina, United States, 27705
Actively Recruiting
25
Clinical Trial Site
Dayton, Ohio, United States, 45459
Actively Recruiting
26
Clinical Trial Site
Philadelphia, Pennsylvania, United States, 19104
Actively Recruiting
27
Clinical Trial Site
Chattanooga, Tennessee, United States, 37403
Actively Recruiting
28
Clinical Trial Site
Knoxville, Tennessee, United States, 37920
Actively Recruiting
29
Clinical Trial Site
Dallas, Texas, United States, 75206
Actively Recruiting
30
Clinical Trial Site
Houston, Texas, United States, 77030
Actively Recruiting
31
Clinical Trial Site
Burlington, Vermont, United States, 05401
Actively Recruiting
32
Clinical Trial Site
Milwaukee, Wisconsin, United States, 53215
Actively Recruiting
33
Clinical Trial Site
Vienna, Austria, 1090
Actively Recruiting
34
Clinical Trial Site
Brampton, Ontario, Canada, L6R 3J7
Actively Recruiting
35
Clinical Trial Site
London, Ontario, Canada, N6A 5A5
Actively Recruiting
36
Clinical Trial Site
Montreal, Quebec, Canada, H2X 3E4
Actively Recruiting
37
Clinical Trial Site
Chengdu, Sichuan, China, 610041
Actively Recruiting
38
Clinical Trial Site
Beijing, China, 100730
Actively Recruiting
39
Clinical Trial Site
Changchun, China, 130021
Actively Recruiting
40
Clinical Trial Site
Chengdu, China, 610072
Actively Recruiting
41
Clinical Trial Site
Guangzhou, China, 510080
Actively Recruiting
42
Clinical Trial Site
Jinan, China, 250021
Actively Recruiting
43
Clinical Trial Site
Nanchang, China, 330006
Actively Recruiting
44
Clinical Trial Site
Qingdao, China, 266003
Actively Recruiting
45
Clinical Trial Site
Shijiazhuang, China, 050000
Actively Recruiting
46
Clinical Trial Site
Hanover, Hannover, Germany, 30625
Actively Recruiting
47
Clinical Trial Site
Milan, Italy, 20133
Actively Recruiting
48
Clinical Trial Site
Naples, Italy, 80138
Actively Recruiting
49
Clinical Trial Site
Abhā, Saudi Arabia, 62523
Actively Recruiting
50
Clinical Trial Site
Jeddah, Saudi Arabia, 22384
Actively Recruiting
51
Clinical Trial Site
Riyadh, Saudi Arabia, 14611
Actively Recruiting
Research Team
A
Alexion Pharmaceuticals, Inc. (Sponsor)
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here